
Lars Klareskog
Articles
-
3 weeks ago |
jbc.org | Tiing Jen Loh |Ravi Sharma |Lars Klareskog
IntroductionRheumatoid arthritis (RA) is a T cell-mediated autoimmune disease which affects primarily the joints, and its progression leads to significant morbidity and reduced life expectancy. The disease has a prevalence of 0.5% worldwide and over 500,000 people in Australia (1,2). A hallmark characteristic of RA is the presence of anti-citrullinated protein antibodies (ACPA) in sera, for which >70% of the RA patients being ACPA seropositive in established RA and prior to disease onset (3-9).
-
Aug 19, 2024 |
unt.se | Lars Klareskog
Lokalt Visa alla orter Uppsala Östhammar Tierp Knivsta Heby Älvkarleby Sigtuna Enköping Håbo Nyheter Senaste nytt Blåljus Ekonomi Valresultat Sport Visa all sport Livesport Senaste nytt Sirius Fotboll Uppsala Fotboll Gusk Dalkurd Almtuna IS Sirius Bandy Storvreta IBK Sirius IBK Hagunda Uppsala Basket SSL Resultat Familj Familjenyheter Se dödsannonser (Till minne) Se familjeannonser Se köp och sälj Skicka in minnesord Skicka in familjeannonser Skicka in Dagens ros Åsikter Alla åsikter Ledare...
-
Jun 9, 2024 |
nature.com | Bruno Raposo |Lars Klareskog |William Robinson |Vivianne Malmström
AbstractSince entering the stage 25 years ago as a highly specific serological biomarker for rheumatoid arthritis, anti-citrullinated protein antibodies (ACPAs) have been a topic of extensive research. This hallmark B cell response arises years before disease onset, displays interpatient autoantigen variability, and is associated with poor clinical outcomes.
-
May 23, 2024 |
acrjournals.onlinelibrary.wiley.com | Anton Öberg Sysojev |Lars Alfredsson |Lars Klareskog |Gilad Silberberg
INTRODUCTION Patients with rheumatoid arthritis (RA) are at increased risk of various comorbid conditions.1-3 Of these, cardiovascular disease (CVD) is among the most prevalent, with studies suggesting a 50% increased risk of CVD incidence among patients with RA compared to the general population.4, 5 Although CVD risk factors are more prevalent among patients with RA than the general population, such factors do not alone explain the entirety of the excess risk,6, 7 leading researchers to...
-
Feb 15, 2024 |
ard.bmj.com | Eleftheria Pertsinidou |Saedis Saevarsdottir |Vivek Anand Manivel |Lars Klareskog
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →